Showing results (1981-1990 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 18, 2002
Comparative cost effectiveness of angiotensin II receptor blockers in a US managed care setting: olmesartan medoxomil compared with losartan, valsartan, and irbesartanW Robert SimonsPharmacoeconomics|December 12, 2001
Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfallsP L Hensley, H G NurnbergPharmacoeconomics|December 12, 2001
Barrett's oesophagus: a review of costs of the illnessM R Arguedas, M A EloubeidiPharmacoeconomics|December 12, 2001
Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancerG L Plosker, M HurstPharmacoeconomics|December 12, 2001
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infectionsM Young, G L PloskerPharmacoeconomics|June 8, 2002
Sickle cell anaemia: epidemiology and cost of illnessPaul J Nietert, Marc D Silverstein, Miguel R AbboudPharmacoeconomics|June 8, 2002
Reporting heterogeneity in the measurement of health and health-related quality of lifeAmir ShmueliPharmacoeconomics|June 8, 2002
Use of healthcare services by patients treated with risperidone versus conventional antipsychotic agentsFrank Gianfrancesco, Michael B Durkin, Ramy Mahmoud, et al.Pharmacoeconomics|July 24, 2001
Hip fracture prevention: cost-effective strategiesP Vestergaard, L Rejnmark, L MosekildePageof 336